Patient characteristics and risk factors of participants and non-participants in the NOR-COR study

John Munkhaugen1, Elise Sverre1, Kari Peersen2

  • 1a Department of Medicine , Drammen Hospital , Drammen , Norway.

Insights

Non-participants in coronary heart disease (CHD) studies often have more risk factors like depression and diabetes. This suggests current prevention studies may overestimate risk factor control in CHD patients.

Area of Science:

  • Cardiology
  • Public Health
  • Clinical Research

Background:

  • Coronary heart disease (CHD) patient populations in clinical studies may not fully represent the general CHD patient demographic.
  • Understanding differences between study participants and non-participants is crucial for accurate clinical research and effective public health strategies.

Purpose of the Study:

  • To compare patient characteristics and coronary risk factors between participants and non-participants in a survey of CHD patients.
  • To identify factors associated with non-participation in CHD clinical studies.

Main Methods:

  • A cross-sectional study analyzed data from hospital medical records of patients hospitalized for acute myocardial infarction and/or revascularization.
  • Compared characteristics and risk factors between study participants (n=1127) and non-participants (n=229) who declined consent.

Main Results:

  • Non-participants exhibited higher prevalence of women (28% vs. 21%), ethnic minorities (6% vs. 3%), living alone (26% vs. 19%), depression (19% vs. 6%), anxiety (9% vs. 3%), hypertension (54% vs. 43%), and diabetes (24% vs. 17%).
  • Significantly higher multi-adjusted odds ratios for non-participation were observed for Charlson comorbidity index (3.4) and depression (14.5).

Conclusions:

  • Non-participants in CHD studies present with a greater burden of coronary risk factors, potentially leading to an overestimation of risk factor control in existing prevention studies.
  • Patients with somatic comorbidity and depression are at higher risk of non-participation.
  • Developing new strategies to address non-adherence is essential for improving secondary prevention in CHD.
Abstract

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
201
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
617
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.5K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.4K